Cargando…
Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo
Mitochondrial dysfunction has been reported in both familial and sporadic Parkinson’s disease (PD). However, effective therapy targeting this pathway is currently inadequate. Recent studies suggest that manipulating the processes of mitochondrial fission and fusion has considerable potential for tre...
Autores principales: | Rappold, Phillip M., Cui, Mei, Grima, Jonathan C., Fan, Rebecca Z., de Mesy-Bentley, Karen L., Chen, Linan, Zhuang, Xiaoxi, Bowers, William J., Tieu, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223875/ https://www.ncbi.nlm.nih.gov/pubmed/25370169 http://dx.doi.org/10.1038/ncomms6244 |
Ejemplares similares
-
Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder
por: Badgaiyan, Rajendra D., et al.
Publicado: (2015) -
Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition
por: Fan, Rebecca Z., et al.
Publicado: (2019) -
Deficits in striatal dopamine release in cannabis dependence
por: van de Giessen, Elsmarieke, et al.
Publicado: (2016) -
D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
por: Lim, Soyeon, et al.
Publicado: (2011) -
Curcumin attenuates neurotoxicity induced by fluoride: An in vivo evidence
por: Sharma, Chhavi, et al.
Publicado: (2014)